{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:06:06Z","timestamp":1784549166978,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031365","name":"Oslo universitetssykehus HF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031365","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.rpth.2026.106637","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T23:42:08Z","timestamp":1778283728000},"page":"106637","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk stratification according to genotype and effect of thromboprophylaxis on obstetric outcomes in women with antithrombin deficiency"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1659-9400","authenticated-orcid":false,"given":"Bj\u00f6rn","family":"Diemer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana","family":"Othman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Lotta","family":"Hempel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roza","family":"Chaireti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Bremme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.106637_bib1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2141.1994.tb04878.x","article-title":"Prevalence of antithrombin deficiency in the healthy population","volume":"87","author":"Tait","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2026.106637_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.6","article-title":"Venous thrombosis","volume":"1","author":"Wolberg","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.rpth.2026.106637_bib3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1538-7836.2005.01197.x","article-title":"Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)","volume":"3","author":"Vossen","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106637_bib4","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2008.02921.x","article-title":"Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study","volume":"6","author":"Pomp","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106637_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0038-1625983","article-title":"Risk of venous thrombosis in antithrombin deficiency: a systematic review and bayesian meta-analysis","volume":"44","author":"Croles","year":"2018","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2026.106637_bib6","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1016\/S2352-3026(20)30007-7","article-title":"Risk of pregnancy-related venous thromboembolism and obstetrical complications in women with inherited type I antithrombin deficiency: a retrospective, single-centre, cohort study","volume":"7","author":"Abbattista","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.rpth.2026.106637_bib7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00277-013-1892-0","article-title":"Prevention, management and extent of adverse pregnancy outcomes in women with hereditary antithrombin deficiency","volume":"93","author":"Rogenhofer","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.rpth.2026.106637_bib8","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1160\/TH16-08-0635","article-title":"Thrombotic risk according to SERPINC1 genotype in a large cohort of subjects with antithrombin inherited deficiency","volume":"117","author":"Alhenc-Gelas","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106637_bib9","first-page":"249","article-title":"Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency","volume":"111","author":"Luxembourg","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106637_bib10","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1365-2516.2008.01830.x","article-title":"Inherited antithrombin deficiency: a review","volume":"14","author":"Patnaik","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.106637_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.thromres.2018.11.006","article-title":"The influence of specific mutations in the AT gene (SERPINC1) on the type of pregnancy related complications","volume":"173","author":"Kovac","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.106637_bib12","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1055\/a-1841-0399","article-title":"Management of antithrombin deficiency in pregnancy","volume":"42","author":"Hart","year":"2022","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.rpth.2026.106637_bib13","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/j.jtha.2025.03.001","article-title":"Hereditary antithrombin deficiency and venous thrombosis in pregnancy-results of a retrospective multicenter study","volume":"23","author":"Dybedal","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106637_bib14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(20)32335-7","article-title":"Pre-eclampsia","volume":"398","author":"Chappell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2026.106637_bib15","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1080\/17474086.2016.1245135","article-title":"Postpartum haemorrhage: prevention and treatment","volume":"9","author":"Sentilhes","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.rpth.2026.106637_bib16","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(21)00682-6","article-title":"Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss","volume":"397","author":"Quenby","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2026.106637_bib17","series-title":"Graviditeter, f\u00f6rlossningar och nyf\u00f6dda barn 2022","year":"2023"},{"key":"10.1016\/j.rpth.2026.106637_bib18","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/ajh.26304","article-title":"High penetrance of inferior vena cava system atresia in severe thrombophilia caused by homozygous antithrombin Budapest 3 variant: description of a new syndrome","volume":"96","author":"de la Morena-Barrio","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2026.106637_bib19","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.jtha.2025.01.015","article-title":"How we treat severe inherited antithrombin deficiency: lessons from cases homozygous for the Budapest 3 variant","volume":"23","author":"Bravo-P\u00e9rez","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106637_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.thromres.2019.01.022","article-title":"SERPINC1 variants causing hereditary antithrombin deficiency in a Danish population","volume":"175","author":"Kjaergaard","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.106637_bib21","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1111\/jth.12364","article-title":"Type II antithrombin deficiency caused by a founder mutation Pro73Leu in the Finnish population: clinical picture","volume":"11","author":"Puurunen","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106637_bib22","article-title":"Age and origin of the founder antithrombin Budapest 3 (p.Leu131Phe) mutation; its high prevalence in the roma population and its association with cardiovascular diseases","volume":"7","author":"Bereczky","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.rpth.2026.106637_bib23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1073\/pnas.81.2.289","article-title":"Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability","volume":"81","author":"Koide","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rpth.2026.106637_bib24","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.8401","article-title":"Preeclampsia prevalence, risk factors, and pregnancy outcomes in Sweden and China","volume":"4","author":"Yang","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.rpth.2026.106637_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","article-title":"Global and regional estimates of preeclampsia and eclampsia: a systematic review","volume":"170","author":"Abalos","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.rpth.2026.106637_bib26","doi-asserted-by":"crossref","first-page":"S1126","DOI":"10.1016\/j.ajog.2020.11.006","article-title":"Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis","volume":"226","author":"Cruz-Lemini","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.rpth.2026.106637_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpobgyn.2024.102481","article-title":"Prevention of preeclampsia","volume":"93","author":"Brownfoot","year":"2024","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.rpth.2026.106637_bib28","article-title":"Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction","volume":"2013","author":"Dodd","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rpth.2026.106637_bib29","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00277-017-2965-2","article-title":"Women with homozygous AT deficiency type II heparin-binding site (HBS) are at high risk of pregnancy loss and pregnancy complications","volume":"96","author":"Kraft","year":"2017","journal-title":"Ann Hematol"},{"key":"10.1016\/j.rpth.2026.106637_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejogrb.2009.12.004","article-title":"Inherited antithrombin deficiency and pregnancy: maternal and fetal outcomes","volume":"149","author":"Sabadell","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.rpth.2026.106637_bib31","article-title":"Inherited antithrombin deficiency in pregnancy","volume":"6","author":"White","year":"2022","journal-title":"Thromb Update"},{"key":"10.1016\/j.rpth.2026.106637_bib32","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/S0140-6736(16)31139-4","article-title":"Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials","volume":"388","author":"Rodger","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2026.106637_bib33","article-title":"Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss","volume":"5","author":"Hamuly\u00e1k","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rpth.2026.106637_bib34","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1080\/14767058.2020.1849116","article-title":"Combined hereditary thrombophilias are responsible for poor placental vascularization development and low molecular weight heparins (LMWH) prevent adverse pregnancy outcomes in these patients","volume":"35","author":"Gojnic","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.rpth.2026.106637_bib35","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/AOG.0000000000002706","article-title":"ACOG Practice Bulletin No. 196: thromboembolism in pregnancy","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.rpth.2026.106637_bib36","article-title":"Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis","volume":"359","author":"Croles","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2026.106637_bib37","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/1358863X17745591","article-title":"Factor V Leiden paradox in a middle-aged Swedish population: a prospective study","volume":"23","author":"Z\u00f6ller","year":"2018","journal-title":"Vasc Med"},{"key":"10.1016\/j.rpth.2026.106637_bib38","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1055\/s-0038-1650289","article-title":"Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency","volume":"75","author":"van Boven","year":"1996","journal-title":"Thromb Haemost"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926032954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926032954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:23:12Z","timestamp":1784546592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037926032954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2475037926032954"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106637","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk stratification according to genotype and effect of thromboprophylaxis on obstetric outcomes in women with antithrombin deficiency","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106637","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"106637"}}